Table 1.
Patient characteristics (N=93).
| Characteristic | n (%) | |
|---|---|---|
| Demographic and clinical characteristics | ||
| Age, years | 65-69 | 29 (31.2) |
| 70-74 | 26 (28.0) | |
| 75-79 | 14 (15.1) | |
| 80+ | 24 (25.8) | |
| Female | 53 (57.0) | |
| Race | White | 59 (63.4) |
| Asian | 24 (25.8) | |
| Black | 5 (5.6) | |
| Other | 5 (5.6) | |
| Primary language | English | 79 (85.0) |
| Chinese | 14 (15.0) | |
| Education | ≤High school | 19 (23.5) |
| College | 37 (45.7) | |
| Graduate level | 25 (30.9) | |
| Partnered | 53 (60.2) | |
| Lives alone | 18 (19.4) | |
| Smoking status | Former smoker | 59 (63.4) |
| Never smoker | 29 (31.2) | |
| Current smoker | 5 (5.4) | |
| Histology | Adenocarcinoma | 77 (82.8) |
| Squamous cell | 12 (12.9) | |
| Other | 4 (4.3) | |
| Stage | IIIA-C | 6 (6.5) |
| IVA | 36 (38.7) | |
| IVB | 51 (54.8) | |
| Brain metastasis | 24 (25.8) | |
| Prior lung cancer treatment | Any prior lung cancer treatment | 66 (71.0) |
| Prior radiation | 40 (43.0) | |
| Prior chemotherapy | 35 (37.6) | |
| Prior targeted therapy | 26 (28.0) | |
| Prior immunotherapy | 17 (18.3) | |
| Prior surgery | 16 (17.2) | |
| Current treatment | Immunotherapy | 33 (35.5) |
| Targeted therapy | 29 (31.2) | |
| Chemotherapy and immunotherapy | 21 (22.6) | |
| Chemotherapy | 10 (10.8) | |
| Pretreatment geriatric assessment and symptom characteristics | ||
| Provider-rated Karnofsky Performance Status <70 | 13 (14.0) | |
| Dependent in ≥1 ADL | 18 (19.4) | |
| Dependent in ≥1 IADL | 55 (66.3) | |
| TUG ≥13.5 sec | 29 (33.3) | |
| SPPB ≤9 | 43 (46.2) | |
| Fall(s) in last 6 months | 12 (14.8) | |
| ≥3 comorbidities | 36 (38.7) | |
| Low hemoglobin (<10 g/dL for women, <11 g/dL for men) | 11 (12.0) | |
| Creatinine clearance <60 ml/min | 33 (36.3) | |
| MoCA score <26 | 63 (67.7) | |
| Involuntary weight loss in last 6 months | 47 (58.0) | |
| BMI <21 kg/m2 | 20 (21.5) | |
| MHI-13 depression score ≥12 | 29 (39.2) | |
| MHI-13 anxiety score ≥6 | 53 (71.6) | |
| Poor tangible social support | 32 (41.0) | |
| High morning fatigue | 30 (38.5) | |
| High evening fatigue | 23 (29.9) | |
| Low morning energy | 61 (78.2) | |
| Low evening energy | 35 (45.5) | |
| Pain (quite a bit or very much) | 20 (26.7) | |
| Shortness of breath (quite a bit or very much) | 19 (25.0) | |
Abbreviations: ADL, activities of daily living; BMI, body mass index; g/dL, gram per deciliter; IADL, instrumental activities of daily living; kg/m2, kilogram per meter square; MHI, Mental Health Inventory; ml/min, milliliters per minute; MoCA, Montreal Cognitive Assessment; TUG, Timed Up and Go; SPPB, Short Physical Performance Battery.
Missing data: education n=12, partner status n=5, IADL n=10, TUG n=6, falls n=12, hemoglobin n=1, creatinine clearance n=2, weight loss n=12, depression n=19, anxiety n=19, social support n=15, morning fatigue/energy n=15, evening fatigue/energy n=16, pain n=18, shortness of breath n=17